Adams Natural Resources Fund Inc. Lowers Position in Corteva, Inc. $CTVA

Adams Natural Resources Fund Inc. trimmed its holdings in shares of Corteva, Inc. (NYSE:CTVAFree Report) by 37.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 57,945 shares of the company’s stock after selling 34,000 shares during the period. Corteva comprises about 0.6% of Adams Natural Resources Fund Inc.’s portfolio, making the stock its 29th largest position. Adams Natural Resources Fund Inc.’s holdings in Corteva were worth $3,884,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of CTVA. Annis Gardner Whiting Capital Advisors LLC lifted its holdings in Corteva by 9.1% during the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 1,674 shares of the company’s stock worth $112,000 after buying an additional 140 shares during the period. Drive Wealth Management LLC raised its stake in shares of Corteva by 3.8% during the 4th quarter. Drive Wealth Management LLC now owns 4,259 shares of the company’s stock worth $285,000 after acquiring an additional 156 shares in the last quarter. Reynders McVeigh Capital Management LLC lifted its position in Corteva by 2.9% during the fourth quarter. Reynders McVeigh Capital Management LLC now owns 5,686 shares of the company’s stock valued at $381,000 after acquiring an additional 160 shares during the last quarter. Chesapeake Capital Corp IL lifted its position in Corteva by 0.9% during the fourth quarter. Chesapeake Capital Corp IL now owns 18,035 shares of the company’s stock valued at $1,209,000 after acquiring an additional 161 shares during the last quarter. Finally, Fox Run Management L.L.C. boosted its stake in Corteva by 5.1% in the third quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company’s stock valued at $227,000 after acquiring an additional 164 shares in the last quarter. Institutional investors own 81.54% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. UBS Group reduced their price target on Corteva from $90.00 to $86.00 and set a “neutral” rating on the stock in a research report on Tuesday. Mizuho boosted their price target on Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 15th. Morgan Stanley upped their price objective on shares of Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Argus increased their price objective on shares of Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research report on Tuesday, March 31st. Finally, Oppenheimer boosted their price objective on shares of Corteva from $86.00 to $89.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.81.

Check Out Our Latest Stock Report on CTVA

Corteva Stock Performance

NYSE CTVA opened at $76.14 on Friday. The firm has a market capitalization of $50.92 billion, a P/E ratio of 44.79, a PEG ratio of 2.33 and a beta of 0.57. The stock has a 50-day simple moving average of $80.39 and a two-hundred day simple moving average of $75.31. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $85.63.

Corteva (NYSE:CTVAGet Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s payout ratio is currently 42.35%.

About Corteva

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Stories

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.